Drug Discovery for Alzheimer's Disease

submitted by: alex01

Gregory Rose from PharmExperts.com interviews J. Buccafusco (Medical College of Georgia, Augusta, GA) about his development of new anti-Altzheimer drugs, designed to act by multiple mechanisms to improve congnition. Desensitization of nicotinic receptors is one of the novel approaches proposed by Buccafusco. Three of his compounds are currently in advanced preclinical evaluation.

Web 2.0 Panel

submitted by: dougramsey

A discussion with Brian Dear from Eventful.com, Seth Greenberg from Intuit.com and Turbotax, and Seth Sternberg from Meebo.com on Web 2.0, online enterpreneurship, user communities, advertising, technology and communication.